Bacterial Pneumonia - Pipeline Review, H2 2016

  • ID: 4020169
  • Report
  • 212 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Abera Bioscience AB
  • AstraZeneca Plc
  • FluGen Inc
  • LegoChem Biosciences Inc
  • Mucosis BV
  • Prometheon Pharma LLC
  • MORE
Bacterial Pneumonia - Pipeline Review, H2 2016

Summary:

The latest Pharmaceutical and Healthcare disease pipeline guide Bacterial Pneumonia - Pipeline Review, H2 2016, provides an overview of the Bacterial Pneumonia (Infectious Disease) pipeline landscape.

Bacterial pneumonia is an infection in one or both lungs. The bacteria cause the lung’s air sacs (alveoli) to become inflamed and engorged with pus, fluid, and cellular debris. This often impairs the body’s ability to exchange oxygen and carbon dioxide. Predisposing factors are age, long-term users of immunosuppressant drugs, chronic obstructive pulmonary disease (COPD) patients who use inhaled corticosteroids for lengthy periods and smokers. Symptoms include cough with yellow, green, or blood-tinged mucus, headache, muscle pain, breathlessness or rapid breathing, lethargy and confusion.

Report Highlights:

The latest Pharmaceutical and Healthcare latest pipeline guide Bacterial Pneumonia - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Bacterial Pneumonia (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Bacterial Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 7, 8, 13, 2, 30, 12 and 1 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Preclinical and Discovery stages comprises 1, 1, 9 and 6 molecules, respectively.

Bacterial Pneumonia (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Bacterial Pneumonia (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Bacterial Pneumonia (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Bacterial Pneumonia (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Bacterial Pneumonia (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Bacterial Pneumonia (Infectious Disease)

Reasons to Buy:

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Bacterial Pneumonia (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Bacterial Pneumonia (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abera Bioscience AB
  • AstraZeneca Plc
  • FluGen Inc
  • LegoChem Biosciences Inc
  • Mucosis BV
  • Prometheon Pharma LLC
  • MORE
Introduction

Bacterial Pneumonia Overview

Therapeutics Development

Bacterial Pneumonia - Therapeutics under Development by Companies

Bacterial Pneumonia - Therapeutics under Investigation by Universities/Institutes

Bacterial Pneumonia - Pipeline Products Glance

Bacterial Pneumonia - Products under Development by Companies

Bacterial Pneumonia - Products under Investigation by Universities/Institutes

Bacterial Pneumonia - Companies Involved in Therapeutics Development

Bacterial Pneumonia - Therapeutics Assessment

Drug Profiles

Bacterial Pneumonia - Dormant Projects

Bacterial Pneumonia - Discontinued Products

Bacterial Pneumonia - Product Development Milestones

Appendix

List of Tables:

Number of Products under Development for Bacterial Pneumonia, H2 2016

Number of Products under Development for Bacterial Pneumonia - Comparative Analysis, H2 2016

Number of Products under Development by Companies, H2 2016

Number of Products under Development by Companies, H2 2016 (Contd..1)

Number of Products under Development by Companies, H2 2016 (Contd..2)

Number of Products under Investigation by Universities/Institutes, H2 2016

Comparative Analysis by Late Stage Development, H2 2016

Comparative Analysis by Clinical Stage Development, H2 2016

Comparative Analysis by Early Stage Development, H2 2016

Comparative Analysis by Unknown Stage Development, H2 2016

Products under Development by Companies, H2 2016

Products under Development by Companies, H2 2016 (Contd..1)

Products under Development by Companies, H2 2016 (Contd..2)

Products under Development by Companies, H2 2016 (Contd..3)

Products under Investigation by Universities/Institutes, H2 2016

Bacterial Pneumonia - Pipeline by Abera Bioscience AB, H2 2016

Bacterial Pneumonia - Pipeline by Actelion Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Affinivax Inc, H2 2016

Bacterial Pneumonia - Pipeline by Allergan Plc, H2 2016

Bacterial Pneumonia - Pipeline by Aridis Pharmaceuticals LLC, H2 2016

Bacterial Pneumonia - Pipeline by Arsanis Inc, H2 2016

Bacterial Pneumonia - Pipeline by AstraZeneca Plc, H2 2016

Bacterial Pneumonia - Pipeline by Beijing Minhai Biotechnology Co Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Biken Inc, H2 2016

Bacterial Pneumonia - Pipeline by ContraFect Corp, H2 2016

Bacterial Pneumonia - Pipeline by Crestone Inc, H2 2016

Bacterial Pneumonia - Pipeline by Daiichi Sankyo Company Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Dong-A Socio Holdings Co Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Double Bond Pharmaceutical International AB, H2 2016

Bacterial Pneumonia - Pipeline by Emergent BioSolutions Inc, H2 2016

Bacterial Pneumonia - Pipeline by FluGen Inc, H2 2016

Bacterial Pneumonia - Pipeline by GlaxoSmithKline Plc, H2 2016

Bacterial Pneumonia - Pipeline by ImmunoBiology Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Indian Immunologicals Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Integrated BioTherapeutics Inc, H2 2016

Bacterial Pneumonia - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Lascco SA, H2 2016

Bacterial Pneumonia - Pipeline by LegoChem Biosciences Inc, H2 2016

Bacterial Pneumonia - Pipeline by LG Life Science LTD, H2 2016

Bacterial Pneumonia - Pipeline by Liquidia Technologies Inc, H2 2016

Bacterial Pneumonia - Pipeline by MedImmune LLC, H2 2016

Bacterial Pneumonia - Pipeline by Merck & Co Inc, H2 2016

Bacterial Pneumonia - Pipeline by Mucosis BV, H2 2016

Bacterial Pneumonia - Pipeline by Noxxon Pharma AG, H2 2016

Bacterial Pneumonia - Pipeline by Panacea Biotec Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Pfizer Inc, H2 2016

Bacterial Pneumonia - Pipeline by Polyphor Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Prometheon Pharma LLC, H2 2016

Bacterial Pneumonia - Pipeline by Sanofi Pasteur SA, H2 2016

Bacterial Pneumonia - Pipeline by Serum Institute of India Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Shionogi & Co Ltd, H2 2016

Bacterial Pneumonia - Pipeline by SK Chemicals Co Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H2 2016

Bacterial Pneumonia - Pipeline by Valneva SE, H2 2016

Bacterial Pneumonia - Pipeline by Vaxxilon AG, H2 2016

Bacterial Pneumonia - Pipeline by Virometix AG, H2 2016

Bacterial Pneumonia - Pipeline by Wellstat Vaccines LLC, H2 2016

Bacterial Pneumonia - Pipeline by Wockhardt Ltd, H2 2016

Assessment by Monotherapy Products, H2 2016

Assessment by Combination Products, H2 2016

Number of Products by Stage and Target, H2 2016

Number of Products by Stage and Mechanism of Action, H2 2016

Number of Products by Stage and Route of Administration, H2 2016

Number of Products by Stage and Molecule Type, H2 2016

Bacterial Pneumonia - Dormant Projects, H2 2016

Bacterial Pneumonia - Dormant Projects (Contd..1), H2 2016

Bacterial Pneumonia - Dormant Projects (Contd..2), H2 2016

Bacterial Pneumonia - Dormant Projects (Contd..3), H2 2016

Bacterial Pneumonia - Dormant Projects (Contd..4), H2 2016

Bacterial Pneumonia - Discontinued Products, H2 2016

List of Figures:

Number of Products under Development for Bacterial Pneumonia, H2 2016

Number of Products under Development for Bacterial Pneumonia - Comparative Analysis, H2 2016

Number of Products under Development by Companies, H2 2016

Number of Products under Investigation by Universities/Institutes, H2 2016

Comparative Analysis by Late Stage Development, H2 2016

Comparative Analysis by Clinical Stage Development, H2 2016

Comparative Analysis by Early Stage Products, H2 2016

Assessment by Monotherapy Products, H2 2016

Assessment by Combination Products, H2 2016

Number of Products by Top 10 Targets, H2 2016

Number of Products by Stage and Top 10 Targets, H2 2016

Number of Products by Top 10 Mechanism of Actions, H2 2016

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016

Number of Products by Routes of Administration, H2 2016

Number of Products by Stage and Routes of Administration, H2 2016

Number of Products by Top 10 Molecule Types, H2 2016

Number of Products by Stage and Top 10 Molecule Types, H2
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abera Bioscience AB
  • Actelion Ltd
  • Affinivax Inc
  • Allergan Plc
  • Aridis Pharmaceuticals LLC
  • Arsanis Inc
  • AstraZeneca Plc
  • Beijing Minhai Biotechnology Co Ltd
  • Biken Inc
  • ContraFect Corp
  • Crestone Inc
  • Daiichi Sankyo Company Ltd
  • Dong-A Socio Holdings Co Ltd
  • Double Bond Pharmaceutical International AB
  • Emergent BioSolutions Inc
  • FluGen Inc
  • GlaxoSmithKline Plc
  • ImmunoBiology Ltd
  • Indian Immunologicals Ltd
  • Integrated BioTherapeutics Inc
  • Kyorin Pharmaceutical Co Ltd
  • Lascco SA
  • LegoChem Biosciences Inc
  • LG Life Science LTD
  • Liquidia Technologies Inc
  • MedImmune LLC
  • Merck & Co Inc
  • Mucosis BV
  • Noxxon Pharma AG
  • Panacea Biotec Ltd
  • Pfizer Inc
  • Polyphor Ltd
  • Prometheon Pharma LLC
  • Sanofi Pasteur SA
  • Serum Institute of India Ltd
  • Shionogi & Co Ltd
  • SK Chemicals Co Ltd
  • Sumitomo Dainippon Pharma Co Ltd
  • Valneva SE
  • Vaxxilon AG
  • Virometix AG
  • Wellstat Vaccines LLC
  • Wockhardt Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll